FDA issued a Warning Letter to Abbott's Compounding Pharmacy, Inc. on 4/4/2017 as a result of this inspection.
483 Abbott's Compounding Pharmacy Jan 2016

483 Abbott's Compounding Pharmacy Jan 2016

Eileen Liu FDA, Ashar Parikh FDA, Dustin Tran FDA$119.00 - Available Now

FDA investigators audited the Abbott's Compounding Pharmacy - Berkeley, CA, United States facility and issued 11 inspectional observations (via FDA 483) on 08 Jan 2016.

Product details

  • Category: Human Drugs
  • Number of Observations: 11
  • Inspection end: 08 Jan 2016
  • Location: Berkeley, United States
  • FEI: 3005529620
Add To Cart